Help Ensure Safe Transitions of Care for Pulmonary Hypertension Patients

It's getting harder to keep up with medications for pulmonary hypertension...especially with more patients on combination therapy.

Help ensure safe transitions of care for these patients.

Continue most meds on admission. Avoid interruptions in prostacyclin therapy...especially IV epoprostenol (Flolan, Veletri, etc) and treprostinil (Remodulin) continuous infusions. Abruptly stopping these can lead to life-threatening rebound pulmonary hypertension.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals